{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:56:51Z","timestamp":1790783811578,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1124\/mol.52.6.1041","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:28:46Z","timestamp":1515443326000},"page":"1041-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Potent Inhibitors of Human Immunodeficiency Virus Type 1 Integrase: Identification of a Novel Four-Point Pharmacophore and Tetracyclines as Novel Inhibitors"],"prefix":"10.1016","volume":"52","author":[{"given":"Nouri","family":"Neamati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.A.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.52.6.1041_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/095632029700800601","article-title":"HIV-1 integrase as a target for antiviral drugs.","volume":"8","author":"Pommier","year":"1997","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1124\/mol.52.6.1041_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1359-6446(97)01105-7","article-title":"Design and discovery of HIV-1 integrase inhibitors.","volume":"2","author":"Neamati","year":"1997","journal-title":"Drug Discovery Today"},{"key":"10.1124\/mol.52.6.1041_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0026-895X(25)09385-X","article-title":"Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.","volume":"50","author":"Robinson","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.6.1041_bib4","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1073\/pnas.93.13.6326","article-title":"Inhibitors of HIV-1 replication that inhibit HIV integrase.","volume":"93","author":"Robinson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.6.1041_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0040-4020(58)88005-9","article-title":"Chicoric acid (dicaffeyltartic acid): its isolation from chicory (Chicorium intybus) and synthesis.","volume":"4","author":"Scarpati","year":"1958","journal-title":"Tetrahedron"},{"key":"10.1124\/mol.52.6.1041_bib6","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/0031-9422(88)80664-2","article-title":"Caffeoyl conjugates from echinacea species: structures and biological activity.","volume":"27","author":"Cheminat","year":"1988","journal-title":"Phytochemistry"},{"key":"10.1124\/mol.52.6.1041_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/095632029300400406","article-title":"Inhibition of HIV infection by caffeoylquinic acid derivatives.","volume":"4","author":"Mahmood","year":"1993","journal-title":"Antiviral. Chem. Chemother."},{"key":"10.1124\/mol.52.6.1041_bib8","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/0006-2952(89)90582-0","article-title":"Characterization of a novel inhibitor of human DNA polymerases: 3,4,5-tri-O- galloylquinic acid.","volume":"38","author":"Parker","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1124\/mol.52.6.1041_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/bss0610103","article-title":"Plant polyphenols: free radical scavenger or chain-breaking antioxidants?","volume":"61","author":"Rice-Evans","year":"1995","journal-title":"Biochem. Soc. Symp."},{"key":"10.1124\/mol.52.6.1041_bib10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/jm960759e","article-title":"Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.","volume":"40","author":"Neamati","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1021\/jm960596u","article-title":"HIV-1 integrase pharmacophore: discovery of inhibitors through 3D database searching.","volume":"40","author":"Nicklaus","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/jm960754h","article-title":"Discovery of HIV-1 integrase inhibitors by pharmacophore searching.","volume":"40","author":"Hong","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib13","doi-asserted-by":"crossref","first-page":"27330","DOI":"10.1074\/jbc.271.44.27330","article-title":"Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site: implications for the role of lysine 136 in DNA binding.","volume":"271","author":"Mazumder","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1124\/mol.52.6.1041_bib14","unstructured":"Mazumder, A., N. Neamati, S. Sunder, J. Owen, and Y. Pommier. Retroviral integrase: a novel target in antiviral development; basic in vitro assays with the purified enzyme, in Methods in Cellular and Molecular Biology: Antiviral Evaluation (D. Kinchington and R. Schinazi, eds.). The Humana Press, Totowa, NJ, in press."},{"key":"10.1124\/mol.52.6.1041_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0026-895X(25)08773-5","article-title":"Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.","volume":"49","author":"Mazumder","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1124\/mol.52.6.1041_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.1738845","article-title":"Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.","volume":"255","author":"Chow","year":"1992","journal-title":"Science (Washington D. C.)"},{"key":"10.1124\/mol.52.6.1041_bib17","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.92.19.8861","article-title":"Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase 1-DNA cleavage sites.","volume":"92","author":"Pommier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.6.1041_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/ci00021a032","article-title":"The NCI drug information system 3D database.","volume":"34","author":"Milne","year":"1994","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1124\/mol.52.6.1041_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/ci00052a002","article-title":"The NCI drug information system.","volume":"26","author":"Milne","year":"1986","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1124\/mol.52.6.1041_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/ci9500849","article-title":"Molecular modeling in the discovery of drug leads.","volume":"36","author":"Milne","year":"1996","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1124\/mol.52.6.1041_bib21","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1021\/jm00052a007","article-title":"The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database search: molecular modeling studies.","volume":"37","author":"Wang","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib22","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1021\/jm950874+","article-title":"Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching.","volume":"39","author":"Wang","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMm: a program for macromolecular energy minimization and dynamics calculations.","volume":"4","author":"Brooks","year":"1983","journal-title":"J. Comput. Chem."},{"key":"10.1124\/mol.52.6.1041_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0968-0896(95)00031-B","article-title":"Conformational changes of small molecules binding to proteins.","volume":"3","author":"Nicklaus","year":"1995","journal-title":"Bioorg. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0006-2952(94)90291-7","article-title":"Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.","volume":"48","author":"Fesen","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1124\/mol.52.6.1041_bib26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/jm960449w","article-title":"Arylamide inhibitors of HIV-1 integrase.","volume":"40","author":"Zhao","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib27","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1073\/pnas.90.6.2399","article-title":"Inhibitors of human immunodeficiency virus integrase.","volume":"90","author":"Fesen","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.6.1041_bib28","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1073\/pnas.93.17.9090","article-title":"Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-\u03baB.","volume":"93","author":"Natarajan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.6.1041_bib29","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1073\/pnas.92.24.11239","article-title":"Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans.","volume":"92","author":"Gnabre","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.6.1041_bib30","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1021\/bi9700328","article-title":"Multiple interaction between polyphenols and a salivary proline-rich protein repeat results in complexation and precipitation.","volume":"36","author":"Baxter","year":"1997","journal-title":"Bichemistry"},{"key":"10.1124\/mol.52.6.1041_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0959-440X(96)80098-4","article-title":"Retroviral integrases and their cousins.","volume":"6","author":"Rice","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1124\/mol.52.6.1041_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.bi.63.070194.001025","article-title":"The retroviral enzymes.","volume":"63","author":"Katz","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1124\/mol.52.6.1041_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0092-8674(91)90297-C","article-title":"HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.","volume":"67","author":"Engelman","year":"1991","journal-title":"Cell"},{"key":"10.1124\/mol.52.6.1041_bib34","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1021\/jm960074e","article-title":"Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.","volume":"39","author":"Mazumder","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1124\/mol.52.6.1041_bib35","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1093\/nar\/19.24.6691","article-title":"Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein.","volume":"19","author":"Vink","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1124\/mol.52.6.1041_bib36","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1073\/pnas.92.13.6057","article-title":"Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues.","volume":"92","author":"Jenkins","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1124\/mol.52.6.1041_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0969-2126(96)00012-3","article-title":"The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.","volume":"4","author":"Bujacz","year":"1996","journal-title":"Structure"},{"key":"10.1124\/mol.52.6.1041_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0040-4020(76)85048-X","article-title":"binding characteristics of tetracycline derivatives in DMSO solution.","volume":"32","author":"Gulbis","year":"1976","journal-title":"Tetrahedron"},{"key":"10.1124\/mol.52.6.1041_bib39","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/ja00842a015","article-title":"A proton nuclear magnetic resonance study of the site of metal binding in tetracycline.","volume":"97","author":"Williamson","year":"1975","journal-title":"J. Am. Chem. Soc."}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24134153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24134153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.52.6.1041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:08:19Z","timestamp":1740046099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24134153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["S0026895X24134153"],"URL":"https:\/\/doi.org\/10.1124\/mol.52.6.1041","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[1997,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent Inhibitors of Human Immunodeficiency Virus Type 1 Integrase: Identification of a Novel Four-Point Pharmacophore and Tetracyclines as Novel Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.52.6.1041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 1997 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}